Link: http://www.digiteklawsuit.org

It seems as though we constantly hear more about pharmaceutical drugs being recalled than about new drugs being approved. Why is this happening? Are the drug companies trying so hard to “push” pharmaceutical drugs to the market place for healthy financials, or is it us, the consumer, who wants cheaper and more effective pharmaceutical drugs “now” for the ever increasing health ailments we seem to have.

Drug recalls fall into several different categories. Class I recalls are for unsafe or defective products that cause serious health problems or death. A Class II drug recall is for products that might cause a temporary health problem and have a low risk of creating a serious problem. Class III recalls for products that violate FDA labeling or manufacturing regulations.

It seems as though every year the drug recalls keep increasing.

Recalls of prescription drugs by major manufacturers is quite common. Recalls may be conducted on a firm's own initiative, by FDA request, or by FDA order under statutory authority. A record of all recalls can be found in the FDA Enforcement Report.

What about the FDA. With all their rules and regulation for the drug companies why are prescription drug recalls still happening in such large numbers. In many instances the FDA does become aware of certain conditions or violations that may lead to a drug recall. Here is an article of a drug recalled called Digitek where the FDA sent a warning letter to Actavis Totowa warning them of failing to follow certain regulatory procedures. Is this an example of one drug recall that may have been avoidable?

When companies realize their products are defective or dangerous, they issue recalls on their own and are required to inform the FDA when the prescription drug recall is started and to make progress reports.Unfortunately many companies fail to initiate their own drug recalls even look into issues that may lead to a drug recall. You would think the negative publicity and financial loss that a drug company may suffer as a result of a pharmaceutical litigation claim would motivate a company to institute a voluntary recall....or is it just wishful thinking?

For more information about the recall see Digitek Lawsuit